About
Evrys Bio develops allosteric, small molecule SIRT2 modulators as therapies to treat a broad spectrum of viral infections while preventing drug resistance.
Explore Evrys Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.